Protective effect of Terminalia chebula against lysosomal enzyme alterations in isoproterenol-induced cardiac damage in rats

Experimental and Clinical Cardiology

Volumn 10, Issue 2, 2005, Pages 91-94

  Suchalatha, Subramaniyan ^a   Devi, Chennam Srinivasulu Shyamala ^a,b  

^a UNIVERSITY OF MADRAS   (India)

^b NONE   (India)

Author keywords

Isoproterenol; Lysosomes; Myocardial injury; Rats; T chebula

Indexed keywords

ALCOHOL; ISOPRENALINE; LYSOSOME ENZYME; TERMINALIA CHEBULA EXTRACT; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; HEART DISEASE; HEART PROTECTION; HERBAL MEDICINE; LYSOSOME MEMBRANE; MALE; NONHUMAN; RAT; TISSUE DISTRIBUTION;

EID: 22144468794     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 1959;67:443-55.
2. Kalra J, Prasad K. Oxygen free radicals and cardiac depression. Clin Biochem 1994:27:163-8.
3. Nadkarni KM. Indian Materia Medica, with Ayurvedic, Unani and Home Remedies. Revised and enlarged by AK MadKarni, 1956. Bombaby: Bombay Popular Prakashan PVP, 1976:1207.
4. Suchalatha S, Shyamala Devi CS. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J Exp Biol 2004;42:174-8.
5. Hashimoto M, Nakajima Y. Antiobesity agents, alpha-amylase inhibitors, lipase inhibitors, foods and beverages containing plant extracts. Jpn Kokai Tokyo Koho JP 1997;227:398.
6. Kato Y, Nagao A, Terao J, Osawa T. Inhibition of mycloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Biosci Biotechnol Biochem 2003;67:1136-9.
7. Cheng HY, Lin TC, Yu KH, Yang CM, Lin CC. Antioxidant and free radical scavenging activities of Terminalia chebula. Biol Pharm Bull 2003;26:1331-5.
8. Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int J Cardiol 1998;67:119-24.
9. Munasinghe TC, Seneviratne CK, Thabrew MI, Abeysekera AM. Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytother Res 2001;15:519-23.
10. Wattiaux R. Lysosomal membranes. In: Jamieson GA, Robinson DM, eds. Mammalian Cell Membranes. London: Buttersworths and Co, 1977:165.
11. Hultberg B, Lindsten J, Sjoblad S. Molecular forms and activities of glycosidases in cultures of amniotic-fluid cells. Biochem J 1976;155:599-605.
12. Conchie J, Gelman AL, Levvy GA. Inhibition of glycosidases by aldonolactones of corresponding configuration. The C-4- and C-6-specificity of beta-glucosidase and beta-galactosidase. Biochem J 1967;103:609-15.
13. Moore JC, Morris JE. A simple automated colorimetric method for determination of N-acetyl-beta-D-glucosaminidase. Ann Clin Biochem 1982;19:157-9.
14. Sapolsky AI, Altman RD, Howell DS. Cathepsin D activity in normal and osteoarthritic human cartilage. Fed Proc 1973;32:1489-93.
15. King J. The hydrolases - acid and alkaline phosphatases. In: Van D, ed. Practical Clinical Enzymology. London: Nostrand, 1965:199-208.
16. Lie JT, Pairolero PC, Holley KE, Titus JL. Macroscopic enzyme mapping verification of large, homogenous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 1975;69:599-605.
17. Wildenthal K, Decker RS, Poole AR, Griffin EE, Dingle JT. Sequential lysosomal alterations during cardiac ischemia. I. Biochemical and immunohistochemical changes. Lab Invest 1978;38:656-61.
18. Welman E, Selwyn AP, Peters TJ, Colbeck JF, Fox KM. Plasma lysosomal enzyme activity in acute myocardial infarction. Cardiovasc Res 1978;12:99-105.
19. Mathew S, Menon PV, Kurup PA. Metabolism of glycosaminoglycans in the heart of rats subjected to isoproterenol-induced myocardial infarction. Indian J Biochem Biophys 1982;19:352-5.
20. Frolov VA, Kapustin VA. [Effect of vitamin A and E on the contractile function of the heart in experimental myocardial infarction]. Kardiologiia 1983;23:93-5.
21. Remla A, Menon PV, Kurup PA. Effect of ethanol administration on changes in metabolism of glycosaminoglycans in heart & aorta in isoproterenol-induced myocardial infarction in rats. Indian J Biochem Biophys 1983;20:295-300.
22. Macickova T, Navarova J, Urbancikova M, Horakova K. Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro. Gen Physiol Biophys 1999;18:86-91.
23. Ravichandran LV, Puvanakrishnan R, Joseph KT. Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats. Biochem Med Metab Biol 1991;45:6-15.
24. Nirmala C, Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 1996;159:85-93.
25. Neely JR, Denton RM, England PJ, Randle PJ. The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem J 1972;128:147-59.
26. Gupta MP, Manchanda SC, Seth SD. Biochemical basis of the protective effect of propanalol pretreatment in experimental myocardial necrosis. Indian J Exp Biol 1982;20:79-83.
27. Decker RS, Wildenthal K. Sequential lysosomal alterations during cardiac ischemia. II. Ultrastructural and cytochemical changes. Lab Invest 1978;38:662-73.
28. Kennett FF, Weglicki WB. Effects of well-defined ischemia on myocardial lysosomal and microsomal enzymes in a canine model. Circ Res 1978;43:750-8.
29. Gottwik MG, Kirk ES, Kennett FF, Weglicki WB. Release of lysosomal enzymes during ischemic injury of canine myocardium. Recent Adv Stud Cardiac Struct Metab 1976;12:431-8.
30. Ogawa T, Hieda N, Sugiyama S, et al. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts. Arzneimittelforschung 1988;38:228-30.
31. Niebes P, Ponard G. Stabilization of rat liver lysosomes by (+)-cyanidanol-3 in vivo. Biochem Pharmacol 1975;24:905-9.
32. Mathew S, Menon PV, Kurup PA. Changes in glycoproteins in isoproterenol-induced myocardial infarction in rats. Indian J Biochem Biophys 1982;19:41-3.
33. Kumar JS, Menon VP. Changes in levels of lipid peroxides and activity of superoxide dismutase and catales in diabetes associated with myocardial infarction. Ind J Exp Biol 1992;30:122-7.
34. Decker RS, Wildenthal K. Role of lysosomes and latent hydrolytic enzymes in ischemic damage and repair of the heart. In: Wildenthal K, ed. Degradative Processes in Heart and Skeletal Muscle. Amsterdam: Elsevier/North Holland Biomedical Press, 1980:389-418.
35. Ebenezar K, Sathish V, Devaki T. Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats. Mol Cell Biochem 2003;247:163-9.
36. Sharma AK, Singh RH. Screening of the anti-inflammatory activity of certain indigenous drugs on carageenin induced hind paw oedema. Bull Med Ethnobot Res 1980;1:262-71.
37. Hanaski Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 1994;16:845-50.
38. Duarte J, Perez Vizcaino F, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol 1993;24:857-62.
39. Miyagi Y, Miwa K, Inoue H. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 1997;80:1627-31.